During the period of support requested in this application, we plan to continue our efforts on the synthesis of potent and specific enzyme inhibitors based on enzyme mechanism data obtained in our laboratory and from the literature. The proposed studies involve a combination of synthetic organic chemistry, mechanistic enzymology, and biochemical pharmacology. The overall goal of our research is to investigate the role of specific biochemical pathways in the control of cell growth. More specifically, in the first portion of the research proposed herein, we will continue our use of fluoroglutamate-containing folates and antifols to assess the role of polyglutamate biosynthesis and hydrolysis in mammalian cells. For example, we will complete the synthesis of gamma-fluoroleucovorin and use it to define the role of polyglutamates in leucovorin """"""""rescue"""""""" of cells following high-dose methotrexate chemotherapy. We will also exploit our recent finding that 3,3-difluoroglutamate (F2Glu) stimulates the formation of polyglutamates in cell-free systems. Following improvement of the synthetic route to F2Glu, we will synthesize a series of F2Glu-containing folates and antifols in order to investigate the biochemical pharmacology of compounds with enhanced ability to form polyglutamate derivatives. In the second portion of the proposed research we will employ our new synthetic methodology for the synthesis of complex acetylenic nucleosides. We will complete the synthesis of our proposed specific """"""""multisubstrate adduct inhibitors"""""""" of methylases with which we have many years of experience (catechol O-methyltransferase, phenethanolamine N-methyltransferase) and study their effect on isolated enzymes. If these proposed new methylase inhibitors are as specific and potent as predicted, we will use them to study catecholamine biosynthesis in neuroblastoma cells. As with the folate work, our ultimate goal in this work is to develop potent and specific inhibitors of each methyltransferase in order to study their role in cell growth and/or cell function.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Research Project (R01)
Project #
5R01CA028097-16
Application #
2087690
Study Section
Experimental Therapeutics Subcommittee 1 (ET)
Project Start
1987-01-01
Project End
1996-11-30
Budget Start
1993-12-01
Budget End
1994-11-30
Support Year
16
Fiscal Year
1994
Total Cost
Indirect Cost
Name
University of Michigan Ann Arbor
Department
Pharmacology
Type
Schools of Pharmacy
DUNS #
791277940
City
Ann Arbor
State
MI
Country
United States
Zip Code
48109
McGuire, John J; Bartley, David M; Tomsho, John W et al. (2009) Inhibition of human folylpolyglutamate synthetase by diastereomeric phosphinic acid mimics of the tetrahedral intermediate. Arch Biochem Biophys 488:140-5
Majumdar, Debatosh; Alexander, Matthew D; Coward, James K (2009) Synthesis of isopeptide epoxide peptidomimetics. J Org Chem 74:617-27
Coward, James K; McGuire, John J (2008) Mechanism-based inhibitors of folylpoly-gamma-glutamate synthetase and gamma-glutamyl hydrolase: control of folylpoly-gamma-glutamate homeostasis as a drug target. Vitam Horm 79:347-73
Tomsho, John W; Moran, Richard G; Coward, James K (2008) Concentration-dependent processivity of multiple glutamate ligations catalyzed by folylpoly-gamma-glutamate synthetase. Biochemistry 47:9040-50
Alexander, Jessica P; Ryan, Thomas J; Ballou, David P et al. (2008) Gamma-glutamyl hydrolase: kinetic characterization of isopeptide hydrolysis using fluorogenic substrates. Biochemistry 47:1228-39
Yang, Yonghong; Coward, James K (2007) Synthesis of p-aminophenyl aryl H-phosphinic acids and esters via cross-coupling reactions: elaboration to phosphinic acid pseudopeptide analogues of pteroyl glutamic acid and related antifolates. J Org Chem 72:5748-58
Bartley, David M; Coward, James K (2006) Regioselective synthesis of alpha-methyl 2-methyleneglutarate via a novel lactonization-elimination rearrangement. J Org Chem 71:372-4
Feng, Yan; Coward, James K (2006) Prodrug forms of N-[(4-deoxy-4-amino-10-methyl)pteroyl]glutamate-gamma-[psiP(O)(OH)]-glutarate, a potent inhibitor of folylpoly-gamma-glutamate synthetase: synthesis and hydrolytic stability. J Med Chem 49:770-88
Bartley, David M; Coward, James K (2005) A stereoselective synthesis of phosphinic acid phosphapeptides corresponding to glutamyl-gamma-glutamate and incorporation into potent inhibitors of folylpoly-gamma-glutamyl synthetase. J Org Chem 70:6757-74
Tomsho, John W; McGuire, John J; Coward, James K (2005) Synthesis of (6R)- and (6S)-5,10-dideazatetrahydrofolate oligo-gamma-glutamates: kinetics of multiple glutamate ligations catalyzed by folylpoly-gamma-glutamate synthetase. Org Biomol Chem 3:3388-98

Showing the most recent 10 out of 39 publications